Last updated: April 15, 2024
Sponsor: Reykjavik University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pain (Pediatric)
Sleep Disorders
Breast Cancer
Treatment
Light Glasses (Comparison)
Light Glasses (Experimental)
Clinical Study ID
NCT04418856
VSN-18-199
Ages > 18 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Breast cancer Patients: Newly diagnosed patients with stages 1 to 3 breast cancerscheduled to undergo surgery (without chemotherapy) and newly diagnosed patients withstages 1 to 3 breast cancer scheduled to undergo both surgery and chemotherapy.
- Healthy controls: never received a cancer diagnosis
Exclusion
Exclusion Criteria:
- Stage 3B breast cancer, inflammatory or stage 4 breast cancer; under age 18;pregnancy; pre-existing anemia (Hb <10gm/dl); history of bipolar disorder or mania (which are contra-indications for BWL treatment); and any other physical orpsychological impairments (e.g., sleep disorder diagnosis) which could limitparticipation.
Study Design
Total Participants: 240
Treatment Group(s): 2
Primary Treatment: Light Glasses (Comparison)
Phase:
Study Start date:
June 08, 2020
Estimated Completion Date:
October 31, 2024
Connect with a study center
Reykjavik University
Reykjavik, 102
IcelandActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.